Sep 30, 2020
Melbourne, Australia; 30 September 2020: Starpharma (ASX: SPL, OTCQX: SPHRY) today provided its latest investor presentation.
Download ASX Announcement: Investor Presentation (pdf file, 3.2MB)
This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction. Any securities described in this announcement have not been, and will not be, registered under the US Securities Act of 1933 and may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration of the US Securities Act and applicable US state securities laws.